News Search Results
Jun 13, 2025, 11:01 ET Electronic Warfare Market Size to Hit $34.10 Billion by 2034, Experiences Growth in Business Aviation Sector | CAGR of 9.4%
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Trending
More news about: The Insight Partners
Jun 13, 2025, 10:35 ET Marler Clark files first Federal Cucumber Lawsuit against grower linked to two Salmonella Outbreaks
Montevideo, multiple other strains of Salmonella, unrelated to this outbreak investigation, matched other isolates in the National Center for Biotechnology Information's database that occurred in 2025 and previous years. CDC is working to determine if additional human illnesses match these additional
More news about: Marler Clark, Inc., P.S.
Jun 13, 2025, 09:00 ET Regor to Present Data on its Lead Obesity Candidate, RGT-075, at the 85th Scientific Sessions of American Diabetes Association (ADA)
June 13, 2025 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a global innovator of clinical-stage biotechnology, today announced that it will present results from its Phase 2a trial of RGT-075 in adults with obesity or overweight with weight-related comorbidities
More news about: Regor Therapeutics
Jun 13, 2025, 09:00 ET Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD'
AQUA AD can provide and meet demand for global expectations. Neurophet will exhibit at the Korea Pavilion, jointly organized by the Korea Biotechnology Industry Organization and the Korea Trade-Investment Promotion Agency (KOTRA), and showcase Neurophet AQUA AD along with its suite of neuroimaging
More news about: Neurophet
Jun 13, 2025, 09:00 ET AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Jun 12, 2025, 22:33 ET Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease
Alzheimer's disease. About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing innovative therapies for neurodegenerative and age-related diseases. Leveraging advanced molecular design, pharmacological
More news about: Merry Life Biomedical Company, Ltd.
Jun 12, 2025, 22:33 ET Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease
Alzheimer's disease. About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing innovative therapies for neurodegenerative and age-related diseases. Leveraging advanced molecular design, pharmacological
More news about: Merry Life Biomedical Company, Ltd.
Jun 12, 2025, 22:23 ET Taiwan Goes All-In for BIO in Boston: 2025's Pavilion Promotes Biotech Innovation, Tech Power, and Global Partnerships
June 11, 2025 /PRNewswire/ -- Taiwan's delegation, led by BPIPO (Biotechnology and Pharmaceutical Industries Promotion Office), organized by the Ministry of Economic Affairs, and supported by various government agencies, will
More news about: The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)
Jun 12, 2025, 18:19 ET PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc.
securities between March 7, 2024 and March 3, 2025. PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic
More news about: Robbins LLP
Jun 12, 2025, 16:48 ET RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Rocket Pharmaceuticals Class Action Lawsuit
[email protected]. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Jun 12, 2025, 13:27 ET Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer
successful entrepreneur and business executive from startup to acquisition. He has worked as a senior executive in clinical trials for pharmaceutical, biotechnology, and med-tech companies seeking to develop their assets into safe and effective treatment options. His experience includes multiple leadership roles
More news about: Dignify Therapeutics
Jun 12, 2025, 11:55 ET LabConnect Selects Deloitte to Streamline Financial and Business Operations
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jun 12, 2025, 11:50 ET Formwork System Market Size is Expected to Grow at 5.53% CAGR with US$ 9.32 Billion by 2031, Driven by Experiences Growing Number of Infrastructure Projects Globally | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 12, 2025, 11:45 ET LabConnect Selects Deloitte to Streamline Financial and Business Operations
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jun 12, 2025, 11:15 ET Fiber Optic Sensor Market Size Reach US$ 6.76 Billion by 2031, Experiences Growth Owing to Rising demand for Structural Health Monitoring | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 12, 2025, 11:00 ET EV Connector Market Size to Surge to USD 12.39 Billion by 2031, Driven by 25.3% CAGR | Experiences Growth Owing to Growing EV Industry
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 12, 2025, 10:29 ET Medical Waste Management Market worth US$59.42 billion by 2030 with 8.0% CAGR | Exclusive Study by The Research Insights
to US$ 59.42 billion by 2030, the Global Medical Waste Management Market represents a significant opportunity for biotechnology firms, recycling technology developers, start-ups focused on eco-friendly disposal solutions, private equity investors, and logistics and transportation
More news about: The Research Insights
Jun 12, 2025, 10:05 ET T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
in health care innovations. The fund's portfolio typically consists of 100 to 150 stocks and is diversified across health care, with a focus on biotechnology, pharmaceuticals, products and device providers, and health care service companies. TMED will be co-managed by Sal Rais,
More news about: T. Rowe Price Group
Jun 12, 2025, 10:00 ET Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
CITY, June 12, 2025 /PRNewswire/ -- Rebel Medicine Inc, a clinical‑stage biotechnology company developing innovative drug delivery systems and non‑opioid pain therapeutics for acute and post-operative pain, announced the closing of
More news about: Rebel Medicine Inc
Jun 12, 2025, 09:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jun 12, 2025, 09:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jun 12, 2025, 08:47 ET NovoLINC Appoints Tech Industry Veteran Bob Wenner as COO to Scale Product for AI Data Center Cooling
M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. M Ventures covers the areas of Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability.
More news about: NovoLINC, Inc.
Jun 12, 2025, 08:33 ET GlycoNex Announces Publication of Preclinical Study on GNX1021, a Novel Glycan-Targeted ADC for Gastric Cancer
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical-stage biotechnology company specializing in glycan-directed cancer immunotherapies, today announced that its first-in-class antibody-drug conjugate (ADC), GNX1021,
More news about: GlycoNex, Inc.
Jun 12, 2025, 08:03 ET Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases
Mass., June 12, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreement with Visterra,
More news about: Nona Biosciences
Jun 12, 2025, 08:02 ET Lafayette Square Provides Financing to Support Ickler Electric's ESOP
Founded in 1985, Ickler Electric specializes in highly technical, mission-critical projects across biotechnology and life sciences, pharmaceutical, laboratory and other commercial industries. Ickler has a robust set of capabilities, including extensive in-house
More news about: Lafayette Square Holding Company